Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Más filtros




Base de datos
Intervalo de año de publicación
1.
Eur J Immunol ; 52(1): 138-148, 2022 01.
Artículo en Inglés | MEDLINE | ID: mdl-34676541

RESUMEN

The interferon pathway, a key antiviral defense mechanism, is being considered as a therapeutic target in COVID-19. Both, substitution of interferon and JAK/STAT inhibition to limit cytokine storms have been proposed. However, little is known about possible abnormalities in STAT signaling in immune cells during SARS-CoV-2 infection. We investigated downstream targets of interferon signaling, including STAT1, STAT2, pSTAT1 and 2, and IRF1, 7 and 9 by flow cytometry in 30 patients with COVID-19, 17 with mild, and 13 with severe infection. We report upregulation of STAT1 and IRF9 in mild and severe COVID-19 cases, which correlated with the IFN-signature assessed by Siglec-1 (CD169) expression on peripheral monocytes. Interestingly, Siglec-1 and STAT1 in CD14+ monocytes and plasmablasts showed lower expression among severe cases compared to mild cases. Contrary to the baseline STAT1 expression, the phosphorylation of STAT1 was enhanced in severe COVID-19 cases, indicating a dysbalanced JAK/STAT signaling that fails to induce transcription of interferon stimulated response elements (ISRE). This abnormality persisted after IFN-α and IFN-γ stimulation of PBMCs from patients with severe COVID-19. Data suggest impaired STAT1 transcriptional upregulation among severely infected patients may represent a potential predictive biomarker and would allow stratification of patients for certain interferon-pathway targeted treatments.


Asunto(s)
COVID-19/inmunología , Monocitos/inmunología , SARS-CoV-2/inmunología , Factor de Transcripción STAT1/inmunología , Transducción de Señal/inmunología , Regulación hacia Arriba/inmunología , Adulto , Anciano , Femenino , Humanos , Factores Reguladores del Interferón/inmunología , Masculino , Persona de Mediana Edad , Gravedad del Paciente , Fosforilación/inmunología
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA